Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.41 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.38 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4698484 | 0.81 | CYP1A2 (0.46) | ESR1ESR2PTGS1PTGS2ALOX5 | |
| SCHEMBL9972713 | 0.80 | ESR1 (0.46) | ESR1ESR2PTGS1PTGS2ALOX5 | |
| SCHEMBL9248538 | 0.79 | ESR1 (0.48) | ESR1ESR2CA1CA2PTGS1 | |
| SCHEMBL8585296 | 0.77 | SLC6A2 (0.46) | ESR1ESR2CA1CA2PTGS1 | |
| SCHEMBL16267848 | 0.76 | ESR1 (0.67) | ESR1ESR2CA1CA2PTGS1 | |
| SCHEMBL7170533 | 0.75 | KDM4E (0.44) | HMGB1CXCL12ALDH1A1CYP3A4MEN1 | |
| SCHEMBL8955025 | 0.74 | ALDH1A1 (0.63) | ESR1ESR2CA1CA2PTGS1 | |
| SCHEMBL17803628 | 0.73 | TSHR (0.52) | CA1CA2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6867820 | 0.73 | ESR1 (0.56) | ESR1ESR2CA1CA2PTGS1 | |
| SCHEMBL3801816 | 0.72 | PTGS1 (0.68) | ESR1ESR2CA1CA2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132240-A1 | LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER | SHPP GLOBAL TECH B V (NL) | 2026-05-14 | — | — | US | disclosed |
| EP-3636692-B1 | POLY(ARYLENE ETHER) COPOLYMER | SHPP GLOBAL TECH BV (NL) | 2026-04-29 | — | — | EP | disclosed |
| US-20260071104-A1 | Anionic Curable Compositions | DESIGNER MOLECULES INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260071103-A1 | Anionic Curable Compositions | DESIGNER MOLECULES INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12503593-B2 | Curable thermosetting composition including poly(arylene ether) copolymer | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-12-23 | — | — | US | disclosed |
| WO-2025224628-A1 | POLYFUNCTIONAL POLY(ARYLENE ETHERS) AND CURABLE COMPOSITIONS THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-30 | — | — | WO | disclosed |
| EP-3919545-B1 | CURABLE THERMOSETTING COMPOSITION INCLUDING POLY(ARYLENE ETHER) COPOLYMER | SHPP GLOBAL TECH BV (NL) | 2025-10-22 | — | — | EP | disclosed |
| EP-3885392-B1 | FUNCTIONALIZED POLY(ARYLENE ETHER) COPOLYMER, METHOD OF MAKING AND ARTICLES OBTAINED THEREFROM | SHPP GLOBAL TECH BV (NL) | 2025-07-02 | — | — | EP | disclosed |
| US-20250197542-A1 | COPOLYMERS DERIVED FROM DICYCLOPENTADIENE | SHPP GLOBAL TECH BV (NL) | 2025-06-19 | — | — | US | disclosed |
| US-20250122328-A1 | COPOLYMERS DERIVED FROM DICYCLOPENTADIENE | SHPP GLOBAL TECNOLOGIES B V (NL) | 2025-04-17 | — | — | US | disclosed |
| US-20040068084-A1 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-04-08 | — | — | US | disclosed |
| US-20040044168-A1 | Phosphorus- and nitrogen-containing resin hardener and a flame retarding resin composition containing said hardener | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-03-04 | — | — | US | disclosed |
| US-20040019134-A1 | Flame retarded epoxy resin composition | CHANG CHUN PLASTICS CO., LTD. | 2004-01-29 | — | — | US | disclosed |
| US-6660786-B2 | Flame retarded epoxy resin composition | CHANG CHUN PLASTICS, CO., LTD. (TW) | 2003-12-09 | — | — | US | disclosed |
| US-6617028-B1 | Oxaphosphophenanthranene-substituted melamines or diaminotriazines; epoxy resins | CHANG CHUN PLASTICS CO., LTD. (TW) | 2003-09-09 | — | — | US | disclosed |
| US-20030073781-A1 | Phosphorus-containing resin and flame retardant resin composition containing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2003-04-17 | — | — | US | disclosed |
| US-20020128397-A1 | Phenolic resins modified with phosphorus oxychloride (POCl3) of given formula; flame retardant properties and high heat resistance so as not to require additional flame retardants; use as electronic packaging material | CHANG CHUN PLASTICS CO. LTD. (TW) | 2002-09-12 | — | — | US | disclosed |
| US-6432539-B1 | ELECTRONIC PACKAGES | CHANG CHUN PLASTICS CO. LTD. (TW) | 2002-08-13 | — | — | US | disclosed |
| US-20020082322-A1 | Flame retarded epoxy resin composition | CHANG CHUN PLASTICS, CO., LTD. (TW) | 2002-06-27 | — | — | US | disclosed |
| US-20020032279-A1 | Flame retardant resin and flame retardant composition containing the same | CHANG CHUN PLASTICS CO., LTD. | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068084-A1 | Azaoxa heterocyclic compound and method of preparing the same | AOX1, KDM1A, BMI1 | ESR1 872/4885ESR2 1941/4885CA1 2550/4885 |
| US-20260071104-A1 | Anionic Curable Compositions | VCL, ITGA8, GABRE | ESR1 467/4885ESR2 1403/4885CA1 1290/4885 |
| US-20260071103-A1 | Anionic Curable Compositions | CDH1, ESD, SETD2 | ESR1 669/4885ESR2 1338/4885CA1 1014/4885 |
| US-20260132240-A1 | LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER | CBLB, UBE4A, PSMD14 | ESR1 681/4885ESR2 1490/4885CA1 4064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.